The Centers for Medicare & Medicaid Services today announced five new Center for Medicare and Medicaid Innovation payment models aimed at transforming kidney care so that patients with chronic kidney disease have access to high-quality, coordinated care. The proposed End-Stage Renal Disease Treatment Choices model would be mandatory for certain areas of the country; four other models are voluntary. The ETC model, which would include dialysis facilities and managing clinicians, would provide new incentives to encourage dialysis in the home. The payment adjustments under the proposed ETC model would begin Jan. 1, 2020, and end June 30, 2026. CMMI said the four optional payment models are expected to enroll more than 200,000 Medicare patients in arrangements that give providers new incentives for preventing kidney disease and managing kidney patients’ health more comprehensively. The payment models are in response to an executive order signed today by President Trump on advancing kidney health. 

Related News Articles

Headline
Aetna’s new “level of severity inpatient payment” policy is now set to take effect Jan. 1, 2026, the company recently announced, along with providing…
Blog
Public
The health care field has entered a period of disruption, from sweeping coverage changes to the rise of artificial intelligence (AI)-enabled tools. The…
Headline
Elizabeth Dabrowski, M.D., pediatric endocrinologist at Children’s Wisconsin, and Matthew Edwards, R.D., diabetes care and education specialist at Children’s…
Chairperson's File
Public
In last month’s Chair File, we talked about some of the key priorities the AHA has for the remainder of 2025, one of which is protecting the 340B Drug Pricing…
Headline
The Centers for Medicare & Medicaid Services is launching a new initiative for state Medicaid programs to purchase prescription drugs at prices aligned…
Headline
The AHA and a coalition of organizations yesterday urged House and Senate leaders to pass the Reforming and Enhancing Sustainable Updates to Laboratory Testing…